Home Lannett Receives FDA Approval for Letrozole Tablets USP 2.5 mg
 

Keywords :   


Lannett Receives FDA Approval for Letrozole Tablets USP 2.5 mg

2014-10-30 13:22:43| Biotech - Topix.net

Lannett Company, Inc. today announced that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Letrozole Tablets USP, 2.5 mg, the therapeutic equivalent to the reference listed drug, FemaraA Tablets, 2.5 mg, of Novartis Pharmaceuticals Corporation. According to IMS, for the year ended September 2014 total sales of Letrozole Tablets USP, 2.5 mg, at Average Wholesale Price were approximately $359 million.

Tags: approval mg receives tablets

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
14.11DX&DX
14.111973
14.11Grand Prix 5000 S TR 25C
14.11PUMA Z 1.2 FG/AG FIRST MILE
14.11.45
14.1163
14.11DVD18
14.11THEE MICHELLE GUN ELEPHANT
More »